The biotechnology instruments market size has grown strongly in recent years. It will grow from $80.9 billion in 2025 to $86.43 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to limited automation in biotechnology labs, dependence on manual sample processing, growing pharmaceutical and biotech research, adoption of conventional diagnostic instruments, increasing demand for laboratory consumables.
The biotechnology instruments market size is expected to see strong growth in the next few years. It will grow to $111.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced lab automation instruments, integration of ai and robotics in research workflows, expansion of genomics and proteomics studies, rising investment in pharmaceutical r&d, adoption of cloud-based data management solutions. Major trends in the forecast period include increasing adoption of lab automation instruments, rising demand for high-throughput screening and analysis, expansion of proteomics and genomics research, growing use of ivd instruments in clinical diagnostics, enhanced focus on quality control and regulatory compliance.
The growing prevalence of chronic diseases is expected to propel the growth of the biotechnology instruments market going forward. Chronic diseases, also referred to as chronic conditions or chronic illnesses, are long-term health issues that typically persist for three months or longer. The prevalence of chronic diseases is influenced by unhealthy lifestyle choices, an aging population, and improved awareness and diagnostic capabilities. Biotechnology instruments contribute to improving patient quality of life by enhancing diagnostic accuracy, optimizing treatment approaches, and enabling effective disease management. These instruments also support the identification of potential drug candidates and facilitate the understanding of their impact on chronic diseases. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia, or pre-diabetes - a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes - in 2023. This represented an 18% increase from 3,065,825 cases recorded in 2022. Therefore, the rising burden of chronic diseases is driving the growth of the biotechnology instruments market.
Leading companies operating in the biotechnology instruments market are focused on developing innovative products, such as single-cell multi-omics solutions, to advance personalized medicine and support genomics, proteomics, and metabolomics research. Single-cell multi-omics solutions are advanced technologies that enable simultaneous analysis of multiple biological data layers from individual cells, including genomics, transcriptomics, proteomics, and metabolomics. For example, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, launched two advanced instruments, the NEO and the Python Junior, to improve standardization across single-cell analysis workflows. The NEO system supports processing of up to half a million cells in a single run across four independent channels, while the Python Junior focuses on efficient dissociation of solid tissues into high-quality single-cell suspensions.
In January 2024, Calibre Scientific, a US-based company engaged in the manufacturing and supply of high-quality laboratory instruments, acquired LabTech S.r.l. for an undisclosed amount. With this acquisition, Calibre Scientific aims to enhance its position in the life sciences sector by expanding its portfolio of laboratory instruments and consumables. LabTech S.r.l. is a UK-based company that manufactures biotechnology instruments, including centrifuges, shakers, incubators, and pipetting systems.
Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics.
North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotechnology instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biotechnology instruments market by increasing costs for imported lab automation systems, reagents, and diagnostic equipment. Segments like robotic liquid handlers, automated plate readers, and molecular diagnostic instruments are most impacted, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs have raised production and procurement costs, they have also encouraged local manufacturing, investment in domestic production, and innovation in cost-effective instrumentation solutions.
The biotechnology instruments market research report is one of a series of new reports that provides biotechnology instruments market statistics, including biotechnology instruments industry global market size, regional shares, competitors with a biotechnology instruments market share, detailed biotechnology instruments market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology instruments industry. This biotechnology instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biotechnology instruments are specialized tools and equipment used in biotechnology laboratories to carry out research, develop products, and perform biological processes. They are essential for manipulating biological systems and advancing fields such as medicine, agriculture, and environmental science.
The main categories of biotechnology instruments include lab automation instruments, life science consumables, and in vitro diagnostic (IVD) instruments. Lab automation instruments are advanced systems developed to carry out repetitive laboratory operations with minimal manual involvement. These instruments are used in applications such as clinical diagnostics, drug discovery and development, proteomics, genomics, cell analysis, and others, and are employed by end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, academic institutions, and research organizations.
The biotechnology instruments market consists of sales of micropipettes, incubators, and autoclaves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biotechnology instruments market size is expected to see strong growth in the next few years. It will grow to $111.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced lab automation instruments, integration of ai and robotics in research workflows, expansion of genomics and proteomics studies, rising investment in pharmaceutical r&d, adoption of cloud-based data management solutions. Major trends in the forecast period include increasing adoption of lab automation instruments, rising demand for high-throughput screening and analysis, expansion of proteomics and genomics research, growing use of ivd instruments in clinical diagnostics, enhanced focus on quality control and regulatory compliance.
The growing prevalence of chronic diseases is expected to propel the growth of the biotechnology instruments market going forward. Chronic diseases, also referred to as chronic conditions or chronic illnesses, are long-term health issues that typically persist for three months or longer. The prevalence of chronic diseases is influenced by unhealthy lifestyle choices, an aging population, and improved awareness and diagnostic capabilities. Biotechnology instruments contribute to improving patient quality of life by enhancing diagnostic accuracy, optimizing treatment approaches, and enabling effective disease management. These instruments also support the identification of potential drug candidates and facilitate the understanding of their impact on chronic diseases. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia, or pre-diabetes - a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes - in 2023. This represented an 18% increase from 3,065,825 cases recorded in 2022. Therefore, the rising burden of chronic diseases is driving the growth of the biotechnology instruments market.
Leading companies operating in the biotechnology instruments market are focused on developing innovative products, such as single-cell multi-omics solutions, to advance personalized medicine and support genomics, proteomics, and metabolomics research. Single-cell multi-omics solutions are advanced technologies that enable simultaneous analysis of multiple biological data layers from individual cells, including genomics, transcriptomics, proteomics, and metabolomics. For example, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, launched two advanced instruments, the NEO and the Python Junior, to improve standardization across single-cell analysis workflows. The NEO system supports processing of up to half a million cells in a single run across four independent channels, while the Python Junior focuses on efficient dissociation of solid tissues into high-quality single-cell suspensions.
In January 2024, Calibre Scientific, a US-based company engaged in the manufacturing and supply of high-quality laboratory instruments, acquired LabTech S.r.l. for an undisclosed amount. With this acquisition, Calibre Scientific aims to enhance its position in the life sciences sector by expanding its portfolio of laboratory instruments and consumables. LabTech S.r.l. is a UK-based company that manufactures biotechnology instruments, including centrifuges, shakers, incubators, and pipetting systems.
Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics.
North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotechnology instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biotechnology instruments market by increasing costs for imported lab automation systems, reagents, and diagnostic equipment. Segments like robotic liquid handlers, automated plate readers, and molecular diagnostic instruments are most impacted, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs have raised production and procurement costs, they have also encouraged local manufacturing, investment in domestic production, and innovation in cost-effective instrumentation solutions.
The biotechnology instruments market research report is one of a series of new reports that provides biotechnology instruments market statistics, including biotechnology instruments industry global market size, regional shares, competitors with a biotechnology instruments market share, detailed biotechnology instruments market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology instruments industry. This biotechnology instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biotechnology instruments are specialized tools and equipment used in biotechnology laboratories to carry out research, develop products, and perform biological processes. They are essential for manipulating biological systems and advancing fields such as medicine, agriculture, and environmental science.
The main categories of biotechnology instruments include lab automation instruments, life science consumables, and in vitro diagnostic (IVD) instruments. Lab automation instruments are advanced systems developed to carry out repetitive laboratory operations with minimal manual involvement. These instruments are used in applications such as clinical diagnostics, drug discovery and development, proteomics, genomics, cell analysis, and others, and are employed by end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, academic institutions, and research organizations.
The biotechnology instruments market consists of sales of micropipettes, incubators, and autoclaves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biotechnology Instruments Market Characteristics
3. Biotechnology Instruments Market Supply Chain Analysis
4. Global Biotechnology Instruments Market Trends and Strategies
5. Biotechnology Instruments Market Analysis of End Use Industries
7. Global Biotechnology Instruments Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biotechnology Instruments Total Addressable Market (TAM) Analysis for the Market
9. Biotechnology Instruments Market Segmentation
10. Biotechnology Instruments Market Regional and Country Analysis
11. Asia-Pacific Biotechnology Instruments Market
12. China Biotechnology Instruments Market
13. India Biotechnology Instruments Market
14. Japan Biotechnology Instruments Market
15. Australia Biotechnology Instruments Market
16. Indonesia Biotechnology Instruments Market
17. South Korea Biotechnology Instruments Market
18. Taiwan Biotechnology Instruments Market
19. South East Asia Biotechnology Instruments Market
20. Western Europe Biotechnology Instruments Market
21. UK Biotechnology Instruments Market
22. Germany Biotechnology Instruments Market
23. France Biotechnology Instruments Market
24. Italy Biotechnology Instruments Market
25. Spain Biotechnology Instruments Market
26. Eastern Europe Biotechnology Instruments Market
27. Russia Biotechnology Instruments Market
28. North America Biotechnology Instruments Market
29. USA Biotechnology Instruments Market
30. Canada Biotechnology Instruments Market
31. South America Biotechnology Instruments Market
32. Brazil Biotechnology Instruments Market
33. Middle East Biotechnology Instruments Market
34. Africa Biotechnology Instruments Market
36. Biotechnology Instruments Market Competitive Landscape and Company Profiles
37. Biotechnology Instruments Market Other Major and Innovative Companies
40. Biotechnology Instruments Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biotechnology Instruments Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biotechnology instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biotechnology instruments? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology instruments market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Lab Automation Instruments; Life Science Consumables; In Vitro Diagnostic (IVD) Instruments2) By Application: Clinical Diagnostics; Drug Discovery And Development; Proteomics And genomics; Cell Analysis; Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Other End Users
Subsegments:
1) By Lab Automation Instruments: Robotic Liquid Handlers; Automated Plate Readers; Automated Workstations; Lab Sample Storage Systems2) By Life Science Consumables: Reagents And Chemicals; Sample Collection And Transport Devices; Laboratory Plasticware; Culture Media And Kits
3) By In Vitro Diagnostic (IVD) Instruments: Molecular Diagnostic Instruments; Clinical Chemistry Analyzers; Hematology Analyzers; Immunoassay Analyzers
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Merck KGaA; Quest Diagnostics Inc.; Avantor Inc.; Agilent Technologies; Illumina Inc.; Sartorius AG; Mettler Toledo; Perkin Elmer Inc.; Shimadzu Corporation; Bruker Corporation; Zeiss Group; QIAGEN N.V.; Novanta Inc.; Cynosure LLC; Bio-Rad Laboratories Inc; Ori Biotech Limited; Hudson Robotics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biotechnology Instruments market report include:- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG
- Merck KGaA
- Quest Diagnostics Inc.
- Avantor Inc.
- Agilent Technologies
- Illumina Inc.
- Sartorius AG
- Mettler Toledo
- Perkin Elmer Inc.
- Shimadzu Corporation
- Bruker Corporation
- Zeiss Group
- QIAGEN N.V.
- Novanta Inc.
- Cynosure LLC
- Bio-Rad Laboratories Inc
- Ori Biotech Limited
- Hudson Robotics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 86.43 Billion |
| Forecasted Market Value ( USD | $ 111.27 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
